- Home
- ERAS vs SUPV Comparison
ERAS vs SUPV Comparison
Compare ERAS & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- SUPV
- Stock Information
- Founded
- ERAS 2018
- SUPV 1887
- Country
- ERAS United States
- SUPV Argentina
- Employees
- ERAS N/A
- SUPV N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- SUPV Commercial Banks
- Sector
- ERAS Health Care
- SUPV Finance
- Exchange
- ERAS Nasdaq
- SUPV Nasdaq
- Market Cap
- ERAS 439.7M
- SUPV 450.9M
- IPO Year
- ERAS 2021
- SUPV 2016
- Fundamental
- Price
- ERAS $2.32
- SUPV $5.07
- Analyst Decision
- ERAS Buy
- SUPV Hold
- Analyst Count
- ERAS 6
- SUPV 3
- Target Price
- ERAS $3.83
- SUPV $17.00
- AVG Volume (30 Days)
- ERAS 1.7M
- SUPV 2.5M
- Earning Date
- ERAS 11-11-2025
- SUPV 11-24-2025
- Dividend Yield
- ERAS N/A
- SUPV 3.70%
- EPS Growth
- ERAS N/A
- SUPV N/A
- EPS
- ERAS N/A
- SUPV 0.09
- Revenue
- ERAS N/A
- SUPV $631,132,570.00
- Revenue This Year
- ERAS N/A
- SUPV $20.63
- Revenue Next Year
- ERAS N/A
- SUPV $22.47
- P/E Ratio
- ERAS N/A
- SUPV $12.03
- Revenue Growth
- ERAS N/A
- SUPV N/A
- 52 Week Low
- ERAS $1.01
- SUPV $4.54
- 52 Week High
- ERAS $3.31
- SUPV $19.75
- Technical
- Relative Strength Index (RSI)
- ERAS 68.53
- SUPV 36.11
- Support Level
- ERAS $1.78
- SUPV $4.54
- Resistance Level
- ERAS $2.65
- SUPV $5.21
- Average True Range (ATR)
- ERAS 0.20
- SUPV 0.47
- MACD
- ERAS 0.05
- SUPV 0.07
- Stochastic Oscillator
- ERAS 68.34
- SUPV 21.06
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About SUPV Grupo Supervielle S.A. each Representing five Class B shares
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.